|
KMID : 0988920170150040524
|
|
Intestinal Research
2017 Volume.15 No. 4 p.524 ~ p.528
|
|
|
Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy
|
|
Lee Way Seah
Azmi Najib
Ng Ruey Terng
Ong Sik Yong
Ponnampalavanar Sasheela Sri La
Mahadeva Sanjiv
Hilmi Ida
|
|
|
Abstract
|
|
|
|
Anti-tumor necrosis factor (anti-TNF) is highly effective in inflammatory bowel disease (IBD); however, it is associated with an increased risk of infections, particularly in older adults. We reviewed 349 patients with IBD, who were observed over a 12-month period, 74 of whom had received anti-TNF therapy (71 patients were aged <60 years and 3 were aged ≥60 years). All the 3 older patients developed serious infectious complications after receiving anti-TNFs, although all of them were also on concomitant immunosuppressive therapy. One patient developed disseminated tuberculosis, another patient developed cholera diarrhea followed by nosocomial pneumonia, while the third patient developed multiple opportunistic infections (Pneumocystis pneumonia, cryptococcal septicemia and meningitis, Klebsiella septicemia). All 3 patients died within 1 year from the onset of the infection(s). We recommend that anti-TNF, especially when combined with other immunosuppressive therapy, should be used with extreme caution in older adult patients with IBD.
|
|
|
KEYWORD
|
|
|
Elderly patients, Anti-tumor necrosis factor, Serious infections
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|